COVINGTON, Ky., Jan. 6, 2011 /PRNewswire/ — Bexion
Pharmaceuticals, LLC announced today that it has added Lester
Crawford, D.V.M., and Ph.D. to its Board of Directors.
Dr. Crawford has had a distinguished career in the public and
private sectors as well as academia. Over ten years of his career
were spent at the Food and Drug Administration (FDA) serving in a
variety of pivotal roles and culminating in his appointment as FDA
Prior to FDA, Dr. Crawford served in many capacities at the
University of Georgia, including chair of the Department of
Physiology and Pharmacology and at Georgetown University where he
was director of the Center for Food and Nutrition Policy. Dr.
Crawford has been an expert advisor to the World Health
Organization, the Singapore FDA and the U. S. Academy of Sciences.
He is currently a Partner and Senior Science Advisor at Policy
“We are excited and privileged to have Dr. Crawford join our
Board of Directors,” stated Dr. Ray Takigiku, Bexion’s co-founder
and CEO. “Dr. Crawford brings us important insights on regulatory
and industry issues that are vital as we approach an IND submission
in 2011, and anticipated clinical trials”, added Dr. Takigiku.
“I am especially pleased to join Bexion’s Board of Directors,”
added Dr. Crawford. “I am looking forward to sharing my experience
over a long career to help Bexion reach its goal of providing
first-in-class, innovative technology to cancer patients
About Bexion Pharmaceuticals:Bexion Pharmaceuticals is
focused on the development and commercialization of innovative
cures for cancer. Initial products are based on a proprietary
platform technology licensed from Cincinnati Children’s Hospital
Medical Center. The technology has demonstrated potential for
development as therapeutic, diagnostic and surgical imaging
reagents, and as carriers for other pharmaceutical agents, such as
oligonucleotides. For mor